Details for New Drug Application (NDA): 072302
✉ Email this page to a colleague
NDA 072302 describes ATENOLOL AND CHLORTHALIDONE, which is a drug marketed by Aurobindo Pharma Usa, Nostrum Labs, Novitium Pharma, Pliva, Sun Pharm Industries, Twi Pharms, Unichem, Watson Labs, and Zydus Pharms, and is included in nine NDAs. It is available from nine suppliers. Additional details are available on the ATENOLOL AND CHLORTHALIDONE profile page.
The generic ingredient in ATENOLOL AND CHLORTHALIDONE is atenolol; chlorthalidone. There are thirty-four drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the atenolol; chlorthalidone profile page.
The generic ingredient in ATENOLOL AND CHLORTHALIDONE is atenolol; chlorthalidone. There are thirty-four drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the atenolol; chlorthalidone profile page.
Summary for 072302
| Tradename: | ATENOLOL AND CHLORTHALIDONE |
| Applicant: | Twi Pharms |
| Ingredient: | atenolol; chlorthalidone |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG;25MG | ||||
| Approval Date: | May 31, 1990 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG;25MG | ||||
| Approval Date: | May 31, 1990 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
